1 August 2024 false No description of principal activity Taxfiler 2024.6 07702236 business:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 07702236 2024-07-31 07702236 2024-08-01 2025-07-31 07702236 business:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 07702236 business:FilletedAccounts 2024-08-01 2025-07-31 07702236 2025-07-31 07702236 2024-07-31 07702236 core:WithinOneYear 2025-07-31 07702236 core:WithinOneYear 2024-07-31 07702236 core:AfterOneYear 2025-07-31 07702236 core:AfterOneYear 2024-07-31 07702236 core:ShareCapital core:PreviouslyStatedAmount 2025-07-31 07702236 core:ShareCapital core:PreviouslyStatedAmount 2024-07-31 07702236 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-07-31 07702236 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-07-31 07702236 core:PreviouslyStatedAmount 2025-07-31 07702236 core:PreviouslyStatedAmount 2024-07-31 07702236 business:SmallEntities 2024-08-01 2025-07-31 07702236 business:Director1 2024-08-01 2025-07-31 07702236 countries:EnglandWales 2024-08-01 2025-07-31 07702236 business:RegisteredOffice 2024-08-01 2025-07-31 07702236 core:PlantMachinery 2024-08-01 2025-07-31 07702236 core:FurnitureFittings 2024-08-01 2025-07-31 07702236 core:PlantMachinery 2024-07-31 07702236 core:FurnitureFittings 2024-07-31 07702236 core:PlantMachinery 2025-07-31 07702236 core:FurnitureFittings 2025-07-31 07702236 business:Director1 1 2024-08-01 2025-07-31 07702236 business:Director1 1 2024-07-31 07702236 business:Director1 1 2025-07-31 07702236 2023-08-01 2024-07-31 iso4217:GBP xbrli:pure
Pure Drug Safety Ltd Statement of financial position as at 31 July 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
230
464
Current assets
Debtors
5
21,058
4,219
Cash at bank and in hand
(4,896)
(4,894)
16,162
(675)
Creditors: amounts falling due within one year
6
(13,157)
(19,056)
Net current assets/(liabilities)
3,005
(19,731)
Total assets less current liabilities
3,235
(19,267)
Creditors: amounts falling due after more than one year
7
(30,855)
(31,507)
Net liabilities
(27,620)
(50,774)
Capital and reserves
Called up share capital
250
250
Profit and loss account
(27,870)
(51,024)
Shareholders' funds
(27,620)
(50,774)
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 April 2026 and were signed on its behalf by
Carol Kingstone Director Company Registration No. 07702236
- 1 -
Pure Drug Safety Ltd Notes to the Accounts for the year ended 31 July 2025
1
Statutory information
Pure Drug Safety Ltd is a private company, limited by shares, registered in England and Wales, registration number 07702236. The registered office is Biocity, Pennyfoot Street, Nottingham, England, NG1 1GF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation had been based on a 33% reducing balance but this policy has been changed to to the following annual rates n order to write off each asset over its estimated useful life
Plant & machinery
25%
Fixtures & fittings
25%
4
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 August 2024
36,813
2,914
39,727
At 31 July 2025
36,813
2,914
39,727
Depreciation
At 1 August 2024
36,348
2,915
39,263
Charge for the year
234
-
234
At 31 July 2025
36,582
2,915
39,497
Net book value
At 31 July 2025
231
(1)
230
At 31 July 2024
465
(1)
464
- 2 -
Pure Drug Safety Ltd Notes to the Accounts for the year ended 31 July 2025
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
234
673
Trade debtors
(1,176)
3,546
Other debtors
22,000
-
21,058
4,219
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
12,850
16,413
Taxes and social security
4
479
Other creditors
-
8
Loans from directors
53
2,156
Accruals
250
-
13,157
19,056
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
30,856
31,505
Other creditors
(1)
2
30,855
31,507
8
Loans to directors
Brought Forward
Advance/ credit
Repaid
Carried Forward
£
£
£
£
Carol Kingstone
See below £22000 repayable by 31.3.2030
-
22,000
-
22,000
-
22,000
-
22,000
At the year end, the company had an outstanding loan to a director, Carol Kingstone. The loan was advanced on or shortly after 1 August 2024 and is unsecured. The balance outstanding at 31 July 2025 was £22,000 (2024: £nil). Interest is charged on the loan at a rate equal to the HMRC Official Rate of Interest. During the year, interest was applied at: 2.25% per annum from 1 August 2024 to 31 March 2025 3.75% per annum from 1 April 2025 onwards Interest is calculated on a simple basis, accruing daily and payable annually in arrears. Repayments of principal will commence from 31.3.25 at £4400 per annum until the loan is fully repaid by 31.3.2030 The loan is repayable in instalments and may be repaid early, in whole or in part, without penalty.
9
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 3 -